R42 Group actively invents and finances deep science ventures.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
R42 Group actively invents and finances deep science ventures. R42 Group will work from the pre-seed inventing stage through to the growth stage.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2022 | KetoSwiss | Seed Round | 0 |
5/2022 | Oxford Drug Design | Convertible Note | 2.7M |
3/2021 | Celeris Therapeutics | Pre Seed Round | 471.5k |
11/2021 | Fountain Therapeutics | Series A | 0 |
7/2021 | VividQ | Seed Round | 15.1M |
2/2022 | Celeris Therapeutics | Seed Round | 3.4M |
5/2022 | Stamp Free | Seed Round | 0 |
7/2021 | Genomelink | Seed Round | 0 |
4/2022 | Exogene | Pre Seed Round | 0 |
3/2021 | Stamp Free | Seed Round | 419.6k |
6/2022 | Spirea Ltd. | Venture Round | 0 |
10/2022 | Silveray | Seed Round | 2.4M |
4/2021 | Concr | Seed Round | 0 |
4/2021 | HexagonFab | Seed Round | 0 |
5/2022 | Bounce Imaging | Series A | 0 |
7/2022 | WiseWorks | Seed | 1.2M |
2/2022 | ExSeed Health | Seed Round | 0 |
7/2022 | WiseWorks | Seed Round | 0 |
6/2022 | Spirea Ltd. | Venture Round | 0 |
5/2022 | Stamp Free | Seed Round | 0 |
5/2022 | Oxford Drug Design | Convertible Note | 0 |
5/2022 | Bounce Imaging | Series A | 0 |
4/2022 | Exogene | Pre Seed Round | 0 |
2/2022 | ExSeed Health | Seed Round | 0 |
2/2022 | Celeris Therapeutics | Seed Round | 0 |
11/2021 | Fountain Therapeutics | Series A | 0 |
7/2021 | Genomelink | Seed Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|